Loading company…
Shape Therapeutics, Inc. (ShapeTX) is a Seattle, US biotechnology company developing RNA technologies for genetic diseases.
Based in Seattle, US, Shape Therapeutics, Inc., trading as ShapeTX, was founded in 2018 by Francois Vigneault, John Suliman and Prashant Mali, and Francois Vigneault is the current CEO. The company develops RNA targeting, RNA editing and RNA replacement technologies, including Payload – RNA Fix, Payload – RNA Skip and Delivery – AAVid, for neurodegenerative, oncology, metabolic and rare genetic diseases. In July 2021 it raised USD 112 million in Series B funding co-led by Breton Capital Ventures and Decheng Capital, with participation from Willett Advisors LLC.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in